News and Features
AIDSinfo Releases First Therapeutic HIV Vaccine Drug Record and New Consumer Materials
Researchers are currently testing a promising treatment option for people with HIV: therapeutic HIV vaccines. Unlike a preventive HIV vaccine, a therapeutic HIV vaccine is designed to improve the body’s immune response to HIV in people who are already infected with the virus. In the future, these vaccines could eliminate HIV from the body, or improve the body’s immune response to the point where antiretroviral therapy is no longer needed.
While the Food and Drug Administration (FDA) has not yet approved any therapeutic HIV vaccines, several experimental vaccines are currently being studied in clinical trials. AIDSinfo has released an investigational drug record for one therapeutic vaccine candidate, AGS-004.
Look for more therapeutic HIV vaccine records to be added to our Drug Database in the coming months.